Sanofi (NASDAQ:SNY) Reaches New 52-Week Low – Time to Sell?

Sanofi (NASDAQ:SNY) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $42.78 and last traded at $42.8140, with a volume of 2598798 shares changing hands. The stock had previously closed at $43.31.

Wall Street Analyst Weigh In

Several research firms have issued reports on SNY. Bank of America downgraded Sanofi from a “buy” rating to a “neutral” rating in a research note on Thursday, February 12th. Argus raised Sanofi to a “strong-buy” rating in a research note on Monday, April 27th. Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a research note on Thursday, March 19th. Citigroup reissued a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th. Finally, Wall Street Zen downgraded Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $51.00.

Sanofi Price Performance

The company has a market cap of $103.66 billion, a P/E ratio of 11.87, a PEG ratio of 1.07 and a beta of 0.35. The company has a fifty day moving average price of $46.17 and a two-hundred day moving average price of $47.76. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.22 and a current ratio of 1.01.

Sanofi Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Wednesday, June 3rd. Stockholders of record on Monday, May 4th will be issued a $2.4225 dividend. This represents a dividend yield of 559.0%. The ex-dividend date is Monday, May 4th. This is a positive change from Sanofi’s previous annual dividend of $2.04. Sanofi’s dividend payout ratio is 49.44%.

Hedge Funds Weigh In On Sanofi

Several hedge funds have recently modified their holdings of SNY. Flagship Harbor Advisors LLC bought a new position in shares of Sanofi in the 4th quarter valued at about $25,000. Physician Wealth Advisors Inc. grew its holdings in shares of Sanofi by 180.5% in the 1st quarter. Physician Wealth Advisors Inc. now owns 589 shares of the company’s stock valued at $28,000 after acquiring an additional 379 shares in the last quarter. Leonteq Securities AG grew its holdings in shares of Sanofi by 95.8% in the 1st quarter. Leonteq Securities AG now owns 607 shares of the company’s stock valued at $29,000 after acquiring an additional 297 shares in the last quarter. Measured Wealth Private Client Group LLC bought a new position in shares of Sanofi in the 3rd quarter valued at about $29,000. Finally, Palisade Asset Management LLC bought a new position in Sanofi during the third quarter worth about $30,000. Institutional investors own 14.03% of the company’s stock.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.